Foley Secures Rare Inter Partes Review Wins for Patent Owner Supernus Pharmaceuticals
10 December 2014
Foley secured three significant inter partes review victories on behalf of Supernus Pharmaceuticals, Inc. and Galderma S.A. for a pharmaceutical product, which represents one of the first inter partes reviews to reach a final decision in favor of the patent owner, where the patents were the subject of a parallel Hatch-Waxman patent litigation. The inter partes reviews were filed by a “generic” company that filed an Abbreviated New Drug application to market a generic version of the product Oracea®.
The Foley team, led by Stephen Maebius, included Andrew Baluch, George Quillin, and Sunit Talapatra.
People
Related News
01 May 2024
Press Releases
Foley Continues to Grow Its East Coast Transactions Practice, Adds M&A Partner Jeff Symons in New York
Foley & Lardner LLP announced today that it has strengthened its Transactions Practice with the addition of M&A partner Jeff Symons in New York.
30 April 2024
Press Releases
Foley Ventures Announces Fifth Fund to Invest in Firm Clients
Foley Ventures is pleased to announce Foley Ventures V, its latest venture fund launched in April 2024 to invest in companies and debt and equity fund clients.
24 April 2024
Press Releases
Nathaniel Lacktman Joins Tampa Bay Wave’s HealthTech|X Accelerator Advisory Council
Foley & Lardner LLP partner Nathaniel “Nate” Lacktman will serve as a member of the Advisory Council for Tampa Bay Wave’s inaugural HealthTech|X Accelerator program, an innovative initiative to support high-potential health technology startups ready to scale in Tampa and beyond.